IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hale Koa who wrote (1309)	3/17/1999 7:45:00 PM
From: Captain Jack	Read Replies (1) of 1510

Hail HALE!!! IMNR should see a jump when the real release comes from the conference... Your paste came from a DOW release which indicates the amount of weight put on the tid bits released SO FAR. No specifics have gone out yet. The most interesting part "In the interim, the principal investigator of the study will submit an application to the Thai government for the registration of Remune in Thailand. The country's minister of health has indicated that the drug would be subject to an accelerated approval process because of near-epidemic levels of HIV infection there, Lawhead said. Last October, Immune Response and Agouron Pharmaceuticals Inc. (AGPH) agreed to collaborate on the development and sale of Remune." Accelerated approval process--- indicates Remune is working very well. Agoron PH Inc (AGPH)--- just purchased by Warner Lambert (WLA) as WLA wanted the drugs in the pipeline equals a direct relationship to a huge company with world wide distribution.. Look for great things FAST! My guess is (Thai is 12 hours different than EST) they will be talking about it in a few hours... Should hit our news services tomorrow! Thurs through Tues will tell the tale.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next